During the past decade, Digestive and Liver Disease Specialists conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 29 clinical trials were completed, i.e. on average, 116% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 17 clinical trials were completed. i.e. 425% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Digestive and Liver Disease Specialists" #1 sponsor was "Gilead Sciences" with 23 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Exact Sciences Corporation" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Digestive and Liver Disease Specialists" #1 collaborator was "Alfasigma S.p.A." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator, "Dr. Naga Chalasani, MD, Indiana University" with 1 trials as a collaborator and "Dr. Stephen A. Harrison, MD, Brooke Army Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Digestive and Liver Disease Specialists" are "Hepatitis C, Chronic" (6 trials), "Nonalcoholic Steatohepatitis" (6 trials), "Chronic Hepatitis C" (5 trials), "Crohn's Disease" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Digestive and Liver Disease Specialists" in a lesser frequency.

Most popular intervention types in "Digestive and Liver Disease Specialists" are "Drug" (52 trials), "Biological" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "RBV" (7 trials), "Sofosbuvir" (4 trials), "placebo" (4 trials) and "GS-9451" (3 trials). Other intervention names were less common.

The vast majority of trials in "Digestive and Liver Disease Specialists" are 65 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Digestive and Liver Disease Specialists". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Digestive and Liver Disease Specialists, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Digestive and Liver Disease Specialists, 0 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Digestive and Liver Disease Specialists has several departments that took part in Clinical trials: "Digestive & Liver Disease Specialists" - 14 trials, "Gastroenterology Consultants" - 2 trials